SCHEMBL24145052

SCHEMBL24145052

CC(=O)O[C@@H]1O[C@H](C(=O)N2CCN(c3ccccc3)CC2)[C@@H](OC(C)O)[C@H](OC(C)=O)[C@H]1OC(C)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TFPI2 P48307 1/20 0.42
▸ MAPK1 P28482 2/20 0.41
▸ MAPT P10636 4/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ KMT2A Q03164 2/20 0.40
▸ TSHR P16473 3/20 0.40
▸ LMNA P02545 2/20 0.40
▸ AKR1C3 P42330 2/20 0.40
▸ TP53 P04637 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ THRB P10828 1/20 0.39
▸ SIGMAR1 Q99720 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ POLB P06746 3/20 0.38
▸ HTT P42858 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ RORC P51449 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20873345 0.92 TFPI2 (0.47) TFPI2MAPTCYP2C9CYP2C19KMT2A
SCHEMBL24145051 0.90 MEN1 (0.45) MAPTKMT2ATSHRLMNAAKR1C3
SCHEMBL24145064 0.89 SMN1; SMN2 (0.47) MAPK1MAPTKMT2AAKR1C3THRB
SCHEMBL24145057 0.89 TP53 (0.43) MAPK1MAPTCYP2C9CYP2C19KMT2A
SCHEMBL24145178 0.87 SMN1; SMN2 (0.42) MAPK1MAPTKMT2ATSHRLMNA
SCHEMBL24145067 0.85 ALDH1A1 (0.48) MAPK1KMT2ATSHRLMNAAKR1C3
SCHEMBL20873341 0.81 AKR1C3 (0.44) TFPI2MAPTKMT2ALMNAAKR1C3
SCHEMBL20873315 0.81 MEN1 (0.50) MAPK1MAPTKMT2ATSHRLMNA
SCHEMBL21112932 0.80 ALDH1A1 (0.51) MAPK1MAPTKMT2ALMNAAKR1C3
SCHEMBL20873248 0.80 ALDH1A1 (0.47) MAPTCYP2C9CYP2C19KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210401946-A1 CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-12-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210401946-A1 CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 TFPI2 2357/4885MAPK1 2200/4885MAPT 3717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback